Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Mar 17:23:eRW1193.
doi: 10.31744/einstein_journal/2025RW1193. eCollection 2025.

Cutaneous manifestations of diabetes mellitus: a narrative review

Affiliations
Review

Cutaneous manifestations of diabetes mellitus: a narrative review

Maria Carolina Mendes de Oliveira Abate et al. Einstein (Sao Paulo). .

Abstract

Diabetes mellitus is a highly prevalent human endocrine disorder. Skin lesions are reported in approximately one-third of all diabetes mellitus patients. The clinical presentation and frequency vary according to the subtype of diabetes mellitus, metabolic control, and clinical course, with certain skin diseases occurring before diagnosing hyperglycemia. In this regard, the correct definition of cutaneous manifestations associated with diabetes mellitus can help define the etiology of hyperglycemia as well as the need to optimize glycemic control. In this narrative review, the most common cutaneous diseases observed in diabetes mellitus are discussed, including pruritus, acanthosis nigricans, necrobiosis lipoidica, bullosis diabeticorum, scleroderma diabeticorum, granuloma annulare, diabetic dermopathy, skin reactions due to device use, diabetic foot ulcers, recurrent cutaneous infections in diabetes mellitus and other dermatoses associated with hyperglycemia. The epidemiology, pathophysiology, differential diagnosis, and treatment of this disease are discussed. Therefore, knowledge and recognition of the most common dermatological lesions in patients with diabetes mellitus are essential for both endocrinologists and primary care physicians.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Hyperchromic velvety plaques in folding areas compatible with acanthosis nigricans (arrow) and diffuse erythema and thickening of the skin, shown by the examiner’s hand, on the upper body compatible with scleredema diabeticorum (asterisk)
Figure 2
Figure 2. A) Erythematous and scaly plaque with a slight yellow tone on the center of the lesion, showing an initial form of necrobiosis lipoidica; B) Deep ulceration with violet erythema surrounding the lesion compatible with a late stage of necrobiosis lipoidica
Figure 3
Figure 3. A and B: Brown, atrophic plaques in an annular pattern on the lower limbs, compatible with granuloma annulare
Figure 4
Figure 4. A and B: Hyperchromic diffuse macules on the lower limbs concentrated in trauma areas, compatible with diabetic dermopathy

References

    1. Jaacks LM, Siegel KR, Gujral UP, Narayan KM. Type 2 diabetes: A 21st century epidemic. Best Pract Res Clin Endocrinol Metab. 2016;30(3):331–343. - PubMed
    1. Perez MI, Kohn SR. Cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol. 1994;30(4):519–531. - PubMed
    1. Lima AL, Illing T, Schliemann S, Elsner P. Cutaneous Manifestations of Diabetes Mellitus: A Review. Am J Clin Dermatol. 2017;18(4):541–553. - PubMed
    1. Hines A, Alavi A, Davis MD. Cutaneous Manifestations of Diabetes. Med Clin North Am. 2021;105(4):681–697. - PubMed
    1. International Diabetes Federation (IDF) IDF Diabetes Atlas. 10th. Belgium: IDF; 2021. [cited 2023 Mar 21]. https://www.diabetesatlas.org

MeSH terms